-
The right nutrition has the power to positively affect eye health. Potent nutrients such as carotenoids and antioxidants have been shown to help maintain eye function, protect eyes against harmful light and reduce the development of age-related eye conditions.
-
We are committed to providing our customers a portfolio of physician-formulated, clinically-validated, independently-certified, ultra-premium dietary supplements to help support, maintain and improve visual health.
Our differences
We’ve made it our mission to create exceptional, nutrient-packed eye health supplements, crafted only from proven, high-quality ingredients.
No compromises
Extensive third-party testing and certifications
What you put in your body matters. Our supplements are formulated according to the highest standards and certifications, providing you with both health benefits and peace of mind.
As nature intended
Crafted from ingredients found in nature
Proven eye health nutrients such as carotenoids and antioxidants, found in everyday foods, can be hard to get enough of from diet alone. Our supplements include premium ingredients that resemble whole natural food to help enhance nutrient availability.
Based in science
Transparent claims about our ingredients
Partnering with leading clinicians and nutritionists, we focus exclusively on health claims where our ingredients have been shown to be beneficial to eye health. We don’t venture beyond the science.
Our Certificates
-
NSF
NSF Dietary Supplement Certification helps consumers and health care providers identify high quality and reliable supplements.
-
Gluten Free
Gluten is a protein found in wheat, barley and rye, but can be hidden in many different food products. Wheat is often used as a filler in supplements. Gluten helps foods maintain their shapes.
-
cGMP
All Eyecheck products are made in cGMP certified facilities. cGMP certified confirms that a manufacturer’s production facility is observing good manufacturing practices established for their industry.
-
Vegan
The Certified Vegan website defines vegan as: no animal or animal by-products to include flesh, bones, dairy, eggs, honey, fur, leather, wool, down feathers, nor tested on animals,or have animal derived GMO’s.
-
GMO
A GMO, or genetically modified organism, may be a plant, animal, microorganism or other organism whose genetics have been modified by using genetic engineering or transgenic technology.
-
Macutene®
5:1 is the ratio of Lutein to Zeaxanthin in Macutene® Protect, which is the ratio found in nature.
Pristene® Brand products are made by Eyecheck, Inc., a proud member of the Council for Responsible Nutrition
The Council for Responsible Nutrition (CRN) and its members share a commitment to improving public health through nutrition, including the appropriate use of dietary supplements and functional food. In pursuit of this goal, CRN’s members pledge to observe and uphold the highest ethical principles in their dealings with their customers, suppliers, competitors, regulators, and consumers in order to foster confidence in our products.
A team of experts
Meet the group of talented people behind Pristene.
-
Tony Moses
CEO
Tony Moses serves as CEO of Eyecheck. He brings over 35 years of experience in ophthalmology. Prior to Eyecheck, Tony was Vice President of Sales at Second Sight (NASDAQ:EYES). Prior to this, he served as Vice President of Global Sales at Oraya Therapeutics. Earlier, he was Global Commercial Vice-President at Neovista. He began his career in ophthalmology at Storz Instruments as Sales Manager for the UK.
-
Rama Jager
M.D., M.B.A., F.A.C.S.
Dr. Rama Jager, founder of Eyecheck and board-certified ophthalmologist, teaches at the University of Illinois at Chicago. Specializing in retinal, vitreous, and macular diseases, he uses advanced technology for various eye conditions and surgeries.
-
John Mahoney
JD, CPA
John Mahoney, general counsel for Eyecheck and President of John Francis Mahoney Law, Ltd., boasts over 25 years of experience as a CPA and lawyer. With a focus on business formation, taxation, governance, and employment matters, he advises both for-profit and not-for-profit clients. Previously a partner at Lawrence Kamin and chairman of the Operations Committee at Chuhak & Tecson, P.C., Mahoney's leadership extends beyond the legal realm. He served as President of the National Association of Investors Corporation’s Chicago Council and began his career as an auditor at Price Waterhouse after graduating from the University of Michigan Law School in 1989.
-
Torsten Kuehn
MANAGING DIRECTOR
Is managing director of ContraCare GmbH. After studying human medicine and completing his doctorate at the Institute of Neurophysiology at the Georg-August University of Göttingen and completing his MBA (business administration) in Hamburg and Beijing, he initially worked as a doctor at the Göttingen University Eye Clinic. From 2006 to 2009, Dr. Kühn worked in the pharmaceutical industry.
-
Ram Palanki
M.D., M.B.A., F.A.C.S.
Dr. Palanki, with over a decade in Ophthalmology, has led in marketing, sales, operations, and more. He earned his Pharm.D from Albany College of Pharmacy, NY, and a postdoctoral fellowship at Rutgers University, NJ.
-
Rohit Varma
M.D., M.P.H.
Dr. Rohit Varma, Professor at USC's Keck School of Medicine, specializes in the epidemiology of eye diseases and glaucoma diagnosis techniques. Formerly Dean and President of USC Care, he leads major eye disease studies and has developed innovative ocular devices. Varma has authored over 320 publications and two books.
-
Peter Kaiser
M.D.
Dr. Kaiser, a vitreoretinal expert at Cleveland Clinic since 1997, leads the Digital OCT Reading Center. A Harvard med graduate, he's also involved in major clinical trials and holds editorial roles. Recognized by top ophthalmology societies, he is also the ophthalmologist for Cleveland's major sports teams.
-
Ahmad Brown
M.D.
J. Ahmad Brown, M.D. is a doubly board-certified pathologist and venture capitalist. He currently serves as CEO of DermTology, Wound Solutions of Georgia, and NuKoDx, while also co-managing HeartX, a cardiovascular-focused healthcare accelerator. He has spent the last 24 years immersed in science and medicine and has focused on democratizing access to precision laboratory services and embracing innovation.
-
Sai Chavala
M.D.
Dr. Sai Chavala, Professor at the North Texas Eye Research Institute, specializes in retinal repair using stem cells. He trained in ophthalmology at Cleveland Clinic, researched at Cornell, and completed a surgical retina fellowship at Duke. Chavala has contributed to over 75 scholarly works and is active in various ophthalmology societies.
-
Michael Singer
M.D.
Dr. Michael Singer, a Vitreoretinal Specialist and Director of Clinical Trials in San Antonio, teaches at the University of Texas Health Science Center. He has led numerous clinical trials, published extensively, and received multiple ophthalmology awards.
-
Subhransu Ray
M.D., Ph.D.
Dr. Subhransu Ray, trained at Harvard, served as Chief Resident and Director of Eye Trauma. Specializing in retinal diseases, he conducts clinical trials and develops treatments for diabetes-related eye conditions. A prolific educator, Dr. Ray also enjoys family time, cooking, gardening, and basketball.